185 related articles for article (PubMed ID: 36800272)
1. DNA Methylation Near CPT1A and Changes in Triglyceride-rich Lipoproteins in Response to Weight-loss Diet Interventions.
Li X; Shao X; Xue Q; Kou M; Champagne CM; Koseva BS; Heianza Y; Grundberg E; Bazzano LA; Bray GA; Sacks FM; Qi L
J Clin Endocrinol Metab; 2023 Jul; 108(8):e542-e549. PubMed ID: 36800272
[TBL] [Abstract][Full Text] [Related]
2. Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study.
Irvin MR; Zhi D; Joehanes R; Mendelson M; Aslibekyan S; Claas SA; Thibeault KS; Patel N; Day K; Jones LW; Liang L; Chen BH; Yao C; Tiwari HK; Ordovas JM; Levy D; Absher D; Arnett DK
Circulation; 2014 Aug; 130(7):565-72. PubMed ID: 24920721
[TBL] [Abstract][Full Text] [Related]
3. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
[No Abstract] [Full Text] [Related]
6. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
[TBL] [Abstract][Full Text] [Related]
7. Methylation at CPT1A locus is associated with lipoprotein subfraction profiles.
Frazier-Wood AC; Aslibekyan S; Absher DM; Hopkins PN; Sha J; Tsai MY; Tiwari HK; Waite LL; Zhi D; Arnett DK
J Lipid Res; 2014 Jul; 55(7):1324-30. PubMed ID: 24711635
[TBL] [Abstract][Full Text] [Related]
8. Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.
Furtado JD; Campos H; Sumner AE; Appel LJ; Carey VJ; Sacks FM
Am J Clin Nutr; 2010 Oct; 92(4):714-22. PubMed ID: 20826623
[TBL] [Abstract][Full Text] [Related]
9. Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III.
Zheng C; Khoo C; Furtado J; Ikewaki K; Sacks FM
Am J Clin Nutr; 2008 Aug; 88(2):272-81. PubMed ID: 18689361
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
Huang Y; Liu XQ; Rall SC; Mahley RW
J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
[TBL] [Abstract][Full Text] [Related]
11. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Björkegren J; Karpe F; Milne RW; Hamsten A
J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
[TBL] [Abstract][Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
13. Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial.
Furtado JD; Campos H; Appel LJ; Miller ER; Laranjo N; Carey VJ; Sacks FM
Am J Clin Nutr; 2008 Jun; 87(6):1623-30. PubMed ID: 18541549
[TBL] [Abstract][Full Text] [Related]
14. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin.
Pieke B; von Eckardstein A; Gülbahçe E; Chirazi A; Schulte H; Assmann G; Wahrburg U
Int J Obes Relat Metab Disord; 2000 Oct; 24(10):1286-96. PubMed ID: 11093290
[TBL] [Abstract][Full Text] [Related]
16. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men.
Kashyap ML; Barnhart RL; Srivastava LS; Perisutti G; Vink P; Allen C; Hogg E; Brady D; Glueck CJ; Jackson RL
J Lipid Res; 1982 Aug; 23(6):877-86. PubMed ID: 7130856
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
[TBL] [Abstract][Full Text] [Related]
18. Changes in soluble LDL receptor and lipoprotein fractions in response to diet in the DIETFITS weight loss study.
Krauss RM; Fisher LM; King SM; Gardner CD
J Lipid Res; 2024 Mar; 65(3):100503. PubMed ID: 38246235
[TBL] [Abstract][Full Text] [Related]
19. Effects of high cholesterol diets on rat plasma lipoproteins and lipoprotein-cell interactions.
Cole TG; Kuisk I; Patsch W; Schonfeld G
J Lipid Res; 1984 Jun; 25(6):593-603. PubMed ID: 6431045
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
